ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Inside A Gene Therapy Facility, Commercialization & Industrialization Project

  An inside look at a clinical-stage company focused on bringing its gene therapy from the lab into a clinical setting for patients and families devastated by rare neurological genetic diseases. 

• Transportation Solutions For Cell And Gene Therapy Supply Chains

  Developing a strong supply chain for your cell and gene therapy can make your company a more attractive target for acquisition as well as a more competitive player in the commercial environment.

• Distributing Clinical Supply In The EU For Compassionate Use Programs

  Explore the logistical and distribution risk management factors that need to be considered when planning an EU Compassionate Use Program, especially when faced with COVID-19 closures and challenges.

• Risk Mitigation Planning For Pharmaceutical Tariffs

  Examine the potential ramifications of proposed tariffs on the pharmaceutical and biotechnology sectors, highlighting critical concerns regarding national security and supply chain stability.

• How Modern RTSM Platforms Are Eliminating Delays

  Stop letting rigid legacy RTSM systems stall your clinical trials. Learn why manual change requests cause months of delays and how a modern, platform-based approach restores your study’s agility.

• Trade Wars And Geopolitical Conflict: Navigating US Tariff Changes And The War In Iran

  Tariffs and geopolitical disruptions are reshaping supply chains. Companies must act now to strengthen continuity planning, evaluate tariff recovery opportunities, and build more resilient logistics strategies for the future.

• How Modern Software Architecture Is Revolutionizing IRT Solutions

  Explore the ways technology suppliers across the clinical trial space have begun investing in IRTs built around a microservices model capable of improving data access and visibility.

• Navigate Complex Ancillary Supply Sourcing Challenges

  Explore the evolvement of the clinical trial landscape over recent years, as well as the new challenges that this poses for the clinical supply chain. 

• Turning Rapid Study Start-Up Into Enrollment Momentum

  A large Phase III ATTR-CM outcomes trial spanning 37 countries reached 50% enrollment eight months early, with monthly accrual rates running 3–5x above plan through coordinated cross-functional execution.

• Overcome Vaccine Development Complexities With The Right Supply Chain Partner

  Explore the challenges impacting clinical supply chains and solutions to overcome these complexities, and understand why it is crucial to pick the right supply chain provider for vaccine storage and distribution.